Gebrauchsinformation: Information für …
Gebrauchsinformation: Information für Anwenderinnen NuvaRing® vaginales Freisetzungssystem, 0,120 mg/0,015 mg pro 24 Stunden, Etonogestrel/Ethinylestradiol
Download Gebrauchsinformation: Information für …
Information
Domain:
Source:
Link to this page:
Documents from same domain
FACHINFORMATION (ZUSAMMENFASSUNG DER MERKMALE …
www.msd.de010175-34859 August 2018 chend senken. FACHINFORMATION (ZUSAMMENFASSUNG DER MERKMALE DER ARZNEIMITTEL) Januvia® 1 1. BEZEICHNUNG DER ARZNEIMITTEL Januvia® 25 mg Filmtabletten Januvia® 50 mg Filmtabletten Januvia® 100 mg Filmtabletten 2.
Related documents
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzHOW TO USE NUVARING The woman herself can insert NuvaRing in the vagina. The physician should advise the woman how to insert and remove NuvaRing.
Patient Information NuvaRing (etonogestrel/ethinyl ...
www.merck.comPatient Information NuvaRing® (NEW-vah-ring) (etonogestrel/ethinyl estradiol vaginal ring) Hormonal birth control methods help to lower the chances of becoming pregnant.
NovaSure Endometrial Ablation & Birth Control
www.novasure.com5. Vaginal Ring (NuvaRing™) A flexible plastic ring inserted into the vagina once a month, slowly releasing the hormones estrogen and progestin. Benefits/Advantages of vaginal rings (NuvaRing) Risks/Disadvantages of vaginal rings (NuvaRing) Failure Rate
30 GYN-AKTIV 6/05 GYNÄKOLOGIE & …
www.patchworkfamily.atgel beim NuvaRing® über die dreiwöchige Dauer der Anwen-dung stabil bei rund 25 pg/ml. Die Serumspiegel beim trans-dermalen Pflaster lagen bereits am Tag 5 …
UNIFIED IPA CONTRACEPTIVE AND INFERTILITY …
www.unifiedipa.comaftera gildess fe 1/20 microgestin 1/20 previfem altavera heather microgestin 24 fe quasense alyacen 1/35 hide tilia fe microgestin fe reclipsen
Choosing a Birth Control Method - ARHP
www.arhp.orgChoosing a Birth Control Method Sep 2011 6 Each section describes the method; presents information on its use, effectiveness, risks, and side effects; and concludes with a